TK216 in Patients with Relapsed or Refractory Ewing Sarcoma - Clinical Trial
What is the Purpose of this Study?
Who Can Participate in the Study?
Adults with a diagnosis of Ewing Sarcoma whose cancer has gotten worse with standard therapy.
What is Involved?
If you choose to join this study, you will:
Be involved in two parts: Screening and Treatment
During Screening, you will have:
- A physical exam
- A urine sample
- Several imaging tests
During Treatment, you will:
- Be admitted to hospital to get study drug
- Get the study drug (TK216), infused through a central line (an I.V.) until your cancer gets worse, or the study doctor takes you off of the study